Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany.
PLoS One. 2020 Jul 1;15(7):e0235091. doi: 10.1371/journal.pone.0235091. eCollection 2020.
Genital psoriasis affects 2-5% of psoriasis patients; generalised plaque or intertriginous psoriasis also affects the genital area in 29-40% of cases. Anogenital psoriasis has been associated with significant quality of life impairments, but little is known about specific patient needs/treatment goals. This study aimed to examine the overall and sex-related disease burden, patient needs and treatment benefits in patients with anogenital psoriasis, compared to patients with psoriasis not affecting the anal/genital areas. Within the cross-sectional nationwide survey, 2,009 participants were consecutively recruited in 157 randomly assigned German dermatology practices and clinics, according to the following inclusion criteria aged 18 years or over; diagnosis of psoriasis vulgaris; ability to answer the questionnaires; and written informed consent. Based on a high-resolution grid on the topical distribution of psoriasis, two groups were formed: anogenital psoriasis (n = 622) and comparison group (n = 1,303). Clinical severity was assessed by the Psoriasis Area and Severity Index (PASI). Patients completed the EuroQoL visual analogue scale (EQ VAS), the Dermatology Life Quality Index (DLQI), and the Patient Benefit Index (PBI). Patients with anogenital psoriasis had higher PASI (13.0±10.6 vs. 8.9±7.6, P < 0.001) and more DLQI impairments (8.9±6.9 vs. 7.0±6.2, P = 0.002) than controls. At the item-level, they also reported more sex-related DLQI impairments (DLQI-i9: 0.5±0.8 vs. 0.3±0.7, P < 0.001) and treatment needs (PBI-i17: 2.2±1.8 vs. 1.9±1.8, P = 0.001). A great percentage of missing/not-relevant responses was found for sex-related items (23.3-41.9%). These results suggest that the assessment of sex-related impairments and treatment needs should be prioritised in patients with anogenital psoriasis. Questionnaires may be used as a less uncomfortable way for patients to discuss their genital lesions and sexual function during healthcare visits. However, the great percentage of missing/not-relevant responses to sex-related items calls for in-depth assessments and effective patient-physician communication regarding these sensitive topics.
生殖器银屑病影响 2-5%的银屑病患者;全身性斑块或间擦性银屑病也会影响 29-40%的生殖器区域。肛门生殖器银屑病与显著的生活质量受损有关,但对特定患者的需求/治疗目标知之甚少。本研究旨在比较肛门生殖器银屑病患者与非肛门/生殖器区域受累的银屑病患者的总体和与性别相关的疾病负担、患者需求和治疗获益。在这项横断面全国性调查中,根据以下纳入标准,在 157 个随机分配的德国皮肤科诊所中连续招募了 2009 名参与者,年龄在 18 岁及以上;诊断为寻常型银屑病;能够回答问卷;并签署书面知情同意书。根据银屑病的局部分布的高分辨率网格,将患者分为两组:肛门生殖器银屑病组(n=622)和对照组(n=1303)。采用银屑病面积和严重程度指数(PASI)评估临床严重程度。患者完成了欧洲生活质量量表视觉模拟评分(EQ VAS)、皮肤病生活质量指数(DLQI)和患者获益指数(PBI)。与对照组相比,肛门生殖器银屑病患者的 PASI(13.0±10.6 比 8.9±7.6,P<0.001)和 DLQI 损伤程度更高(8.9±6.9 比 7.0±6.2,P=0.002)。在项目层面,他们还报告了更多与性相关的 DLQI 损伤(DLQI-i9:0.5±0.8 比 0.3±0.7,P<0.001)和治疗需求(PBI-i17:2.2±1.8 比 1.9±1.8,P=0.001)。与性相关项目的缺失/不相关回答比例很高(23.3-41.9%)。这些结果表明,在肛门生殖器银屑病患者中,应优先评估与性相关的损伤和治疗需求。问卷可作为患者在就诊期间讨论其生殖器病变和性功能的一种不太尴尬的方式。然而,与性相关项目的缺失/不相关回答比例很高,这需要深入评估,并就这些敏感话题进行有效的医患沟通。